Literature DB >> 1664542

The phagocyte oxidative metabolism function in ankylosing spondylitis.

D Wendling1, J M Didier, D A Vuitton.   

Abstract

The phagocyte oxydative metabolism function was measured using chemiluminescence in microamounts of whole blood in 15 ankylosing spondylitis (AS) patients (10 were B27 positive), and in 17 controls. It was obtained from cells at rest, and following stimulation (latex, zymosan, fMLP), with luminol and lucigenin as amplifiers. The maximal light intensity was significantly higher (P less than 0.01) in AS compared to the controls in resting cells as well as in those after stimulation. There was no difference between HLA-B27 positive or negative AS patients. The increase in oxidative metabolism of the phagocyte system in AS was more evident in the luminol dependent assay, suggesting an activation of the myeloperoxydase system.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1664542     DOI: 10.1007/bf00332560

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  7 in total

1.  Role of myeloperoxidase in intracellular and extracellular chemiluminescence of neutrophils.

Authors:  H L Nurcombe; S W Edwards
Journal:  Ann Rheum Dis       Date:  1989-01       Impact factor: 19.103

2.  Polymorphonuclear leucocyte function and previous yersinia arthritis: enhanced chemokinetic migration and oxygen radical production correlate with the severity of the acute disease.

Authors:  P Koivuranta-Vaara; M Leirisalo-Repo; H Repo
Journal:  Ann Rheum Dis       Date:  1987-04       Impact factor: 19.103

3.  Polymorphonuclear leucocyte function and previous yersinia arthritis: correlation of enhanced superoxide production with late manifestations.

Authors:  H Repo; P Koivuranta-Vaara; M Leirisalo-Repo
Journal:  Ann Rheum Dis       Date:  1988-06       Impact factor: 19.103

4.  Blood polymorphonuclear behavior in patients with ankylosing spondylitis.

Authors:  A el Abbouyi; J L Paul; M Roch-Arveiller; L Moachon; M Dougados; J P Giroud; B Amor; D Raichvarg
Journal:  Clin Exp Rheumatol       Date:  1988 Oct-Dec       Impact factor: 4.473

5.  Polymorphonuclear cell motility, ankylosing spondylitis, and HLA B27.

Authors:  C T Pease; J N Fordham; H L Currey
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

6.  Differential inhibition of neutrophil superoxide generation by nonsteroidal antiinflammatory drugs.

Authors:  J C Gay; J N Lukens; D K English
Journal:  Inflammation       Date:  1984-06       Impact factor: 4.092

7.  Chemiluminescence in microamounts of whole blood for investigation of the human phagocyte oxidative metabolism function.

Authors:  B Descamps-Latscha; A T Nguyen; R M Golub; M N Feuillet-Fieux
Journal:  Ann Immunol (Paris)       Date:  1982 May-Jun
  7 in total
  9 in total

1.  A simple, sensitive, non-stimulated photon counting system for detection of superoxide anion in whole blood.

Authors:  F J Lu; J T Lin; H P Wang; W C Huang
Journal:  Experientia       Date:  1996-02-15

2.  Predicting the potential ankylosing spondylitis-related genes utilizing bioinformatics approaches.

Authors:  Hao Zhao; Dan Wang; Deyu Fu; Luan Xue
Journal:  Rheumatol Int       Date:  2014-11-29       Impact factor: 2.631

3.  The oxidative metabolism of circulating phagocytes in ankylosing spondylitis: determination by whole blood chemiluminescence.

Authors:  K J Ho; P Q Chen; C Y Chang; F J Lu
Journal:  Ann Rheum Dis       Date:  2000-05       Impact factor: 19.103

4.  The effect of anti-TNF agent on oxidation status in patients with ankylosing spondylitis.

Authors:  Murat Karkucak; Erhan Capkin; Ahmet Alver; Ayse Akyuz; Abdulkadir Kiris; Emel Ak; Murat Topbas; Mehmet Tosun
Journal:  Clin Rheumatol       Date:  2009-12-11       Impact factor: 2.980

5.  Evaluation of serum paraoxonase and arylesterase activities in ankylosing spondylitis patients.

Authors:  Fazile Hatipoglu Erdem; Saliha Karatay; Kadir Yildirim; Ahmet Kiziltunc
Journal:  Clinics (Sao Paulo)       Date:  2010-02       Impact factor: 2.365

6.  Neutrophil degranulation by Helicobacter pylori proteins.

Authors:  A Nøorgaard; L P Andersen; H Nielsen
Journal:  Gut       Date:  1995-03       Impact factor: 23.059

7.  Serum nitric oxide, catalase, superoxide dismutase, and malondialdehyde status in patients with ankylosing spondylitis.

Authors:  Salih Ozgocmen; Sadik Sogut; Ozge Ardicoglu; Ersin Fadillioglu; Irfan Pekkutucu; Omer Akyol
Journal:  Rheumatol Int       Date:  2003-06-17       Impact factor: 2.631

8.  Serum oxidative-antioxidative status in patients with ankylosing spondilitis.

Authors:  Mehmet Karakoc; Ozlem Altindag; Huseyin Keles; Neslihan Soran; Sahabettin Selek
Journal:  Rheumatol Int       Date:  2007-04-19       Impact factor: 2.631

9.  Association of cytokine and matrix metalloproteinase profiles with disease activity and function in ankylosing spondylitis.

Authors:  Derek L Mattey; Jonathan C Packham; Nicola B Nixon; Lucy Coates; Paul Creamer; Sarah Hailwood; Gordon J Taylor; Ashok K Bhalla
Journal:  Arthritis Res Ther       Date:  2012-05-28       Impact factor: 5.156

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.